BTK and diffuse large B-cell lymphoma: We have previously identified a robust signature of active BCR signaling in DLBCL on formalin-fixed paraffin-embedded specimens based on quantitative immunofluorescence (qIF) of phosphorylated BCR-associated kinases SYK, LYN and BTK [16].